Sentences with phrase «in annual financial reports»

That is the stark conclusion of a new report from consultancy giant KPMG, which reveals that 72 percent of large and mid-cap companies worldwide do not acknowledge the financial risks of climate change in their annual financial reports.

Data on employer contributions for these plans are available in annual financial reports for each fund, which are surveyed by the National Association of State Retirement Administrators (NASRA).

The final audited financial results are provided in the Annual Financial Report usually released about eight months after the end of the fiscal year (March 31), with detailed information tabled in the Public Accounts of Canada shortly thereafter.

As reported in the Annual Financial Report for fiscal year 2011 - 12, the deficit for In 2011 - 12 was $ 1.4 billion higher than estimated in the March 2012 Budget.

We can not understand why this wasn't disclosed in the Annual Financial Report.

The Department of Finance, in the Annual Financial Report, also reported that the annual lapse in direct program expenses was again higher than forecast in the April Budget for 2014 - 15.

The federal Department of Finance released the final audited financial results for 2011 - 12 in its Annual Financial Report (AFR) on Friday, October 5, 2012.

The Department of Finance released the audited financial results for 2010 - 11 today (October 12, 2011) in its Annual Financial Report (AFR).

Final audited financial results for 2016 - 17 were released on September 19th by the Department of Finance in the Annual Financial Report.

On October 5, 2012, the federal Department of Finance released the audited financial results for 2011 - 12 in its Annual Financial Report (AFR).

The Department of Finance released the final audited financial results for 2012 - 13 in its Annual Financial Report (AFR).

However, the Department of Finance notes in its Annual Financial Report for 2009 - 2010 that the increase was attributable to exceptional one - time factors.

The classification of expenses in budget documents is not the same as that used in Annual Financial Report, the Public Accounts or the Fiscal Monitor.

SEGA Sammy has revealed in their annual financial report that the Persona series has exceeded the Shin Megami Tensei sereies.

Capcom's annual net income is at its lowest since 2004, the publisher revealed today in its annual financial report.

The Charitable Trust keeps the administrative fees to a minimum as is reflected in the annual financial report which is posted to this web site.

Not exact matches

In its latest Annual Report, it argued that «even if inflation does not rise, keeping interest rates too low for long could raise financial stability and macroeconomic risks further down the road, as debt continues to pile up and risk - taking in financial markets gathers steam.&raquIn its latest Annual Report, it argued that «even if inflation does not rise, keeping interest rates too low for long could raise financial stability and macroeconomic risks further down the road, as debt continues to pile up and risk - taking in financial markets gathers steam.&raquin financial markets gathers steam.»

The annual report from financial services company Credit Suisse estimates there were 15.4 million U.S. millionaires in 2017, up from 14.3 million in 2016.

For a glossary of other financial terms used in this press release, we refer you to the Company's most recent annual report on Form 10 - K filed with the SEC on February 15, 2018 and subsequent periodic filings with the SEC.

The Insurance Commission of Western Australia increased spending on the Bell Group litigation to $ 9.6 million last financial year, while also revealing in its annual report it has applied to the Supreme Court for a single trial to cover all related matters.

This selected financial information should be read in conjunction with the consolidated financial statements and notes thereto included in Alkermes plc's Annual Report on Form 10 - Q for the three months ended March 31, 2018, which the company intends to file in April 2018.

These risks and uncertainties include, among others: the unfavorable outcome of litigation, including so - called «Paragraph IV» litigation and other patent litigation, related to any of our products or products using our proprietary technologies, which may lead to competition from generic drug manufacturers; data from clinical trials may be interpreted by the FDA in different ways than we interpret it; the FDA may not agree with our regulatory approval strategies or components of our filings for our products, including our clinical trial designs, conduct and methodologies and, for ALKS 5461, evidence of efficacy and adequacy of bridging to buprenorphine; clinical development activities may not be completed on time or at all; the results of our clinical development activities may not be positive, or predictive of real - world results or of results in subsequent clinical trials; regulatory submissions may not occur or be submitted in a timely manner; the company and its licensees may not be able to continue to successfully commercialize their products; there may be a reduction in payment rate or reimbursement for the company's products or an increase in the company's financial obligations to governmental payers; the FDA or regulatory authorities outside the U.S. may make adverse decisions regarding the company's products; the company's products may prove difficult to manufacture, be precluded from commercialization by the proprietary rights of third parties, or have unintended side effects, adverse reactions or incidents of misuse; and those risks and uncertainties described under the heading «Risk Factors» in the company's most recent Annual Report on Form 10 - K and in subsequent filings made by the company with the U.S. Securities and Exchange Commission («SEC»), which are available on the SEC's website at www.sec.gov.

Further, PDC urges you to carefully review and consider the cautionary statements and disclosures, specifically those under the heading «Risk Factors,» made in its Quarterly Report on Form 10 - Q, its Annual Report on Form 10 - K for the year ended December 31, 2016 (the «2016 Form 10 - K»), filed with the U.S. Securities and Exchange Commission («SEC») on February 28, 2017 and amended on May 1, 2018, and other filings with the SEC for further information on risks and uncertainties that could affect the Company's business, financial condition, results of operations, and prospects, which are incorporated by this reference as though fully set forth herein.

The company has a market cap of $ 1.77 billion, but its year - over-year gross profits reported in its recent annual financial statement amounted to $ 20 million in losses.

«Tighter global monetary policy is needed in order to contain inflation pressures and ward off financial stability risks,» the Basel - based central bank of central banks warned in its most recent annual report.

«Although we are pleased with these annual results, this relatively short - term performance is far less meaningful than our long - term results as financial markets can move sharply in either direction over shorter time horizons,» CPPIB chief executive Mark Wiseman said Friday as the fund manager released its annual report for the year ended March 31.

Actual results may differ materially from those indicated by these forward - looking statements as a result of various important factors including, but not limited to, the effects of any unexpected difficulty in closing our financial books for the quarter and other factors that are discussed in the Company's Annual Report on Form 10 - K, quarterly reports on Form 10 - Q, and other documents periodically filed with the SEC.

Certain risk factors that may affect our business operations, financial condition and results of operations are included in our filings with the SEC, including our annual reports on Form 10 - K, quarterly reports on Form 10 - Q and current reports on Form 8 - K.

Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward - looking statements include, among others, the following: our ability to successfully and profitably market our products and services; the acceptance of our products and services by patients and healthcare providers; our ability to meet demand for our products and services; the willingness of health insurance companies and other payers to cover Cologuard and adequately reimburse us for our performance of the Cologuard test; the amount and nature of competition from other cancer screening and diagnostic products and services; the effects of the adoption, modification or repeal of any healthcare reform law, rule, order, interpretation or policy; the effects of changes in pricing, coverage and reimbursement for our products and services, including without limitation as a result of the Protecting Access to Medicare Act of 2014; recommendations, guidelines and quality metrics issued by various organizations such as the U.S. Preventive Services Task Force, the American Cancer Society, and the National Committee for Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Forfinancial condition to differ materially from those indicated in the forward - looking statements include, among others, the following: our ability to successfully and profitably market our products and services; the acceptance of our products and services by patients and healthcare providers; our ability to meet demand for our products and services; the willingness of health insurance companies and other payers to cover Cologuard and adequately reimburse us for our performance of the Cologuard test; the amount and nature of competition from other cancer screening and diagnostic products and services; the effects of the adoption, modification or repeal of any healthcare reform law, rule, order, interpretation or policy; the effects of changes in pricing, coverage and reimbursement for our products and services, including without limitation as a result of the Protecting Access to Medicare Act of 2014; recommendations, guidelines and quality metrics issued by various organizations such as the U.S. Preventive Services Task Force, the American Cancer Society, and the National Committee for Quality Assurance regarding cancer screening or our products and services; our ability to successfully develop new products and services; our success establishing and maintaining collaborative, licensing and supplier arrangements; our ability to maintain regulatory approvals and comply with applicable regulations; and the other risks and uncertainties described in the Risk Factors and in Management's Discussion and Analysis of Financial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on ForFinancial Condition and Results of Operations sections of our most recently filed Annual Report on Form 10 - K and our subsequently filed Quarterly Reports on Form 10 - Q.

Among the factors that could cause actual results to differ materially are the following: (1) worldwide economic, political, and capital markets conditions and other factors beyond the Company's control, including natural and other disasters or climate change affecting the operations of the Company or its customers and suppliers; (2) the Company's credit ratings and its cost of capital; (3) competitive conditions and customer preferences; (4) foreign currency exchange rates and fluctuations in those rates; (5) the timing and market acceptance of new product offerings; (6) the availability and cost of purchased components, compounds, raw materials and energy (including oil and natural gas and their derivatives) due to shortages, increased demand or supply interruptions (including those caused by natural and other disasters and other events); (7) the impact of acquisitions, strategic alliances, divestitures, and other unusual events resulting from portfolio management actions and other evolving business strategies, and possible organizational restructuring; (8) generating fewer productivity improvements than estimated; (9) unanticipated problems or delays with the phased implementation of a global enterprise resource planning (ERP) system, or security breaches and other disruptions to the Company's information technology infrastructure; (10) financial market risks that may affect the Company's funding obligations under defined benefit pension and postretirement plans; and (11) legal proceedings, including significant developments that could occur in the legal and regulatory proceedings described in the Company's Annual Report on Form 10 - K for the year ended Dec. 31, 2017, and any subsequent quarterly reports on Form 10 - Q (the «Reports&rreports on Form 10 - Q (the «Reports&rReports»).

Companies like Nortel and their clones get away with this trick by claiming in their annual and quarterly reports that typical financial reporting does not do justice to the company's so - called potential.

In performing its responsibilities, the Audit Committee has reviewed and discussed with management and the independent auditors the audited consolidated financial statements in Google's Annual Report on Form 10 - K for the year ended December 31, 201In performing its responsibilities, the Audit Committee has reviewed and discussed with management and the independent auditors the audited consolidated financial statements in Google's Annual Report on Form 10 - K for the year ended December 31, 201in Google's Annual Report on Form 10 - K for the year ended December 31, 2014.

These integrated audits serve as a basis for the auditors» opinions included in the annual report to stockholders addressing whether the financial statements fairly present the Company's financial position, results of operations, and cash flows in conformity with U.S. generally accepted accounting principles and whether the Company's internal control over financial reporting was effective as of December 31, 2007.

Factors that could cause or contribute to actual results differing from our forward - looking statements include risks relating to: failure of DBRS to rate the Notes at the anticipated ratings levels, which is a closing condition, or at all; changes in the financial markets, including changes in credit markets, interest rates, securitization markets generally and our proposed securitization in particular; the willingness of investors to buy the Notes; adverse developments regarding OnDeck, its business or the online or broader marketplace lending industry generally, any of which could impact what credit ratings, if any, are issued with respect to the Notes; the extended settlement cycle for the scheduled closing on April 17, 2018, which may exacerbate the foregoing risks; and other risks, including those described in our Annual Report on Form 10 - K for the year ended December 31, 2017 and in other documents that we file with the Securities and Exchange Commission from time to time which are or will be available on the Commission's website at www.sec.gov.

In addition, this Update again failed to incorporate the reclassification changes to Fiscal Arrangements and Alternative Payments for Standing Programs, which were included in the Public Accounts of Canada, the Annual Financial Report for 2011 - 12 and Fiscal MonitoIn addition, this Update again failed to incorporate the reclassification changes to Fiscal Arrangements and Alternative Payments for Standing Programs, which were included in the Public Accounts of Canada, the Annual Financial Report for 2011 - 12 and Fiscal Monitoin the Public Accounts of Canada, the Annual Financial Report for 2011 - 12 and Fiscal Monitor.

The assumptions used in the valuation of these awards are set forth in the notes to our consolidated financial statements, which are included in our Annual Report on Form 10 - K for the year ended December 31, 2017, filed with the SEC on February 23, 2018.

Management's Discussion - Management's Discussion is when the controlling registrants must comply with all the off - balance sheet arrangements of discovery requirements in registering the statements, annual reports and the substitute or information statements that expected are to include the financial statements for their fiscal years ending on or after June.

Each year in their annual reports, in fact, their respective boards of trustees describe the programs» financial woes in excruciating detail.

We read over 3,000 annual reports a year in order to remove accounting distortions found in the financial footnotes.

These will be fully accrued and audited, and later presented as the Annual Financial Report this summer, but in the meantime this is a pretty accurate look at the fiscal year that was.

You can find a narrative explanation of a company's financial performance in a section of the quarterly or annual report entitled, «Management's Discussion and Analysis of Financial Condition and Results of Operationfinancial performance in a section of the quarterly or annual report entitled, «Management's Discussion and Analysis of Financial Condition and Results of OperationFinancial Condition and Results of Operations.»

These include the information presented in the Budget, the monthly Fiscal Monitor, the Annual Financial Report and the Public Accounts of Canada.

All amounts are in Canadian dollars and are based on our audited Annual and unaudited Interim Consolidated Financial Statements for the year and quarter ended October 31, 2015 and related notes prepared in accordance with International Financial Reporting Standards (IFRS).

Walmart's independent accountants are responsible for auditing Walmart's annual consolidated financial statements in accordance with the standards of the Public Company Accounting Oversight Board, and for auditing the effectiveness of Walmart's internal control over financial reporting.

Franzel, in a speech at the American Accounting Association annual meeting in early August said that, despite the fact auditors have been making some progress in improving their audits of internal controls over company financial reporting, the regulator continues to see auditors having trouble meeting the standards and some firms still have significant work to do to meet the requirements of PCAOB auditing standards.

We discuss certain of these matters more fully, as well as certain other risk factors that may affect Centene's business operations, financial condition and results of operations, in Centene's filings with the SEC, including the annual report on Form 10 - K, quarterly reports on Form 10 - Q and current reports on Form 8 - K.

The company is in the process of restating the affected financial statements and the restated financial statements will be included in the company's Annual Report on Form 10 - K for the year ended December 31, 2015, which the company intends to file with the Securities and Exchange Commission and the Canadian Securities Regulators on or before April 29, 2016.

Management of the company, the Audit and Risk Committee (the «Committee») and the Board have concluded that the company's audited financial statements for the year ended, and unaudited financial statements for the quarter ended, December 31, 2014 included in the company's Annual Report on Form 10 - K and the unaudited financial statements included in the company's Quarterly Report on Form 10 - Q for the quarter ended March 31, 2015 should no longer be relied upon due to the misstatements described in the company's Form 8 - K filed today.

The Adjusted Financial Information should be read in conjunction with the Company's historical financial statements and notes thereto contained in the Company's quarterly reports on Form 10 - Q and annual report on ForFinancial Information should be read in conjunction with the Company's historical financial statements and notes thereto contained in the Company's quarterly reports on Form 10 - Q and annual report on Forfinancial statements and notes thereto contained in the Company's quarterly reports on Form 10 - Q and annual report on Form 10 - K.

For the second year in a row, TPUB's annual 10 - K filing has had to note «material weaknesses in the Company's internal control over financial reporting.»